<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04074148</url>
  </required_header>
  <id_info>
    <org_study_id>2019/783</org_study_id>
    <nct_id>NCT04074148</nct_id>
  </id_info>
  <brief_title>Effectiveness of Diabetes Prevention Education Program on Diabetes Prevention Among Prediabetes Population in Nepal</brief_title>
  <acronym>DiPEP</acronym>
  <official_title>Effectiveness of Diabetes Prevention Education Program on Diabetes Prevention Among Prediabetes Population in Nepal: A Cluster Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kathmandu University School of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: The prediabetes population is a high risk group for developing diabetes and is&#xD;
      also associated with a higher risk of micro- and macrovascular complications. Prevalence of&#xD;
      prediabetes is also increasing in Nepal (10.3%). Therefore, appropriate strategies should be&#xD;
      developed to detect prediabetes and prevent its complications. Early detection of prediabetes&#xD;
      offers opportunity for intervention to prevent diabetes either by reverting into&#xD;
      normoglycemia or stabilizing blood glucose levels. Even a small shift in weight loss and&#xD;
      reduction of glycated haemoglobin (HbA1c) (i.e., a change in HbA1c of 0.5%) can be&#xD;
      significant in reducing cardiometabolic risk. Therefore, we propose to develop a culturally&#xD;
      tailored Diabetes Prevention Education Program (DiPEP) for Nepal and implement this program&#xD;
      among a prediabetes population with the aim to prevent diabetes.&#xD;
&#xD;
      Aims: Primary aim of the research is to test the effectiveness of a Diabetes Prevention&#xD;
      Education Program (DiPEP) in lowering glycated haemoglobin (HbA1c %) among a pre-diabetes&#xD;
      population in Nepal. Our secondary aims are to test the effectiveness of DiPEP in improving&#xD;
      health literacy in diabetes, reducing weight, improving healthy diet and physical activity.&#xD;
      We also aim to explore acceptability and usability of DiPEP among a prediabetes population&#xD;
      and perception of adoption and sustainability of DiPEP in the health sector of Nepal.&#xD;
&#xD;
      Significance: Prevention of diabetes, especially Type 2 Diabetes Mellitus (T2DM) is proven,&#xD;
      possible and powerful. It is more cost effective than spending huge money in treatment and&#xD;
      usual care. It requires modification of dietary and exercise behavior, which are efficacious,&#xD;
      safe, and cost-effective measures. Therefore, a culturally tailored DiPEP intervention&#xD;
      program for Nepal will serve as an additional reference resource for the Non-Communicable&#xD;
      Disease division of Ministry of health to develop and implement national diabetes prevention&#xD;
      program if they decide such program is important for Nepal. It will be helpful to achieve&#xD;
      Non-communicable disease target 3.4 of the Sustainable Development Goal by Nepal government's&#xD;
      Ministry of Health. Additionally, it will be beneficial for the prediabetes population who&#xD;
      could have developed T2DM in short span of time if they had been undiagnosed and&#xD;
      unconsidered. Therefore, the main significance of the study is it will provide knowledge and&#xD;
      environment to prevent diabetes at their community level.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 25, 2019</start_date>
  <completion_date type="Actual">September 30, 2021</completion_date>
  <primary_completion_date type="Actual">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>cluster randomized controlled trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>glycated haemoglobin (HbA1c) percent</measure>
    <time_frame>6 months</time_frame>
    <description>testing capillary blood sugar by point of care HbA1c Analyser</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Prediabetic State</condition>
  <arm_group>
    <arm_group_label>Diabetes Prevention Education Program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diabetes Prevention Education Program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diabetes Prevention Education brochure</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diabetes Prevention Education Program</intervention_name>
    <description>An educational lifestyle modification program, offering 4 sessions of 30 minutes theory and 30 minutes practice each, total duration 6 months</description>
    <arm_group_label>Diabetes Prevention Education Program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diabetes Prevention Education brochure</intervention_name>
    <description>An educational lifestyle modification brochure</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Permanent residents of Dhulikhel municipality or Lalitpur Metropolitan City (Patan)&#xD;
&#xD;
          -  Indian Diabetes Risk Score 60 or higher&#xD;
&#xD;
          -  Prediabetes: glycated haemoglobin (HbA1c) 5.7-6.4 %&#xD;
&#xD;
          -  Random blood sugar ≥ 140 to ≤ 250 mg/dl&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  type 1 diabetes (self-report)&#xD;
&#xD;
          -  Type 2 diabetes&#xD;
&#xD;
          -  Under medication&#xD;
&#xD;
          -  HbA1c criteria (≥ 6.5 %)&#xD;
&#xD;
          -  Currently pregnant&#xD;
&#xD;
          -  Critically ill patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bård E Kulseng, phd prof</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology NTNU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kathmandu University School of Medical Science</name>
      <address>
        <city>Kathmandu</city>
        <country>Nepal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nepal</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 28, 2019</study_first_submitted>
  <study_first_submitted_qc>August 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2019</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Patient Education</keyword>
  <keyword>Nepal</keyword>
  <keyword>Diabetes prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

